Loading clinical trials...

Post-Market Study of the 3DKnee™ System | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00819481

Post-Market Study of the 3DKnee™ System

The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.

Lead sponsor: Encore Medical, L.P.•8 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Encore Medical, L.P.

Related studies

RECRUITINGPhase 3

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

NCT07226258 · Osteoarthritis Knee Pain

An Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis

NCT07627542 · Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and more

RECRUITINGPhase 2

Desloratadine as Adjunct Therapy for Rheumatoid Arthritis

NCT07632872 · Rheumatoid Arthritis (RA), Rheumatoid Arthritis

FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis

NCT07625150 · Patellofemoral Osteoarthritis, Knee Osteoarthritis, and more

RECRUITINGPhase 1/2

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935 · Systemic Sclerosis, Idiopathic Inflammatory Myopathies, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 16, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment229

Start dateFeb 2009

Last updatedMar 16, 2021

Condition

Degenerative Joint Disease Osteoarthritis Rheumatoid Arthritis Traumatic Arthritis

Locations shown

Longo Orthopedics

Scottsdale, Arizona

Center for Excellence

Fresno, California

OrthoMaryland

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 16, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions